The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Glucagon-Like Peptide-1 Inhibits Apoptosis of Insulin-Secreting Cells via a Cyclic 5′-Adenosine Monophosphate-Dependent Protein Kinase A- and a Phosphatidylinositol 3-Kinase-Dependent Pathway
Abstract
The activation of the glucagon-like peptide-1 (GLP-1) receptor has been shown to have an important role in the functional activity of islet beta-cells and in the expansion of the islet cell mass. Constant remodeling of islet cell mass is mediated in vivo by proliferative and apoptotic stimuli to ensure a dynamic response to a changing demand for insulin. The present study was undertaken to investigate the biological activity of GLP-1 when cells were challenged by a proapoptotic stimulus. We have shown that activation of the GLP-1 receptor inhibits H(2)O(2)-induced apoptosis in a cultured mouse insulinoma cell line, termed MIN6. GLP-1 reduced DNA fragmentation and improved cell survival. This was mediated by an increased expression of the antiapoptotic proteins Bcl-2 and Bcl-xL. GLP-1 also prevented the H(2)O(2)-dependent cleavage of poly-(ADP-ribose)-polymerase. Inhibition of the GLP-1-dependent increase of cAMP by Rp-cAMP blocked the antiapoptotic action of GLP-1, as determined by DNA fragmentation and poly-(ADP-ribose)-polymerase assays and by detection of Bcl-2 and Bcl-xL protein levels. Investigation of the role of the protein kinases, PI-3 kinase (PI3K) and MAPK, by use of the inhibitors PD098059 and LY294002 demonstrated that the activation of PI3K, but not MAPK, was required to prevent proapoptotic events in cells exposed to H(2)O(2). The present study provides evidence that GLP-1 has an antiapoptotic action mediated by a cAMP- and PI3K-dependent signaling pathway.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Caspases: the executioners of apoptosis
COHEN, G. M. (1997) · Biochemical Journal · doi:10.1042/bj3260001 · Cited by 4,719
Morphologic and biochemical hallmarks of apoptosis
Saraste, A. (2000) · Cardiovascular Research · doi:10.1016/s0008-6363(99)00384-3 · Cited by 1,466
Desagher, S., Osen-Sand, A., Nichols, A., Eskes, R., Montessuit, S., Lauper, S., Maundrell, K., Antonsson, B., & Martinou, J.-C. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.144.5.891 · Cited by 1,262
Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus
Lorenzo, A., Razzaboni, B., Weir, G. C., & Yankner, B. A. (1994) · Nature · doi:10.1038/368756a0 · Cited by 820
WANG, X., MARTINDALE, J. L., LIU, Y., & HOLBROOK, N. J. (1998) · Biochemical Journal · doi:10.1042/bj3330291 · Cited by 736
Pick, A., Clark, J., Kubstrup, C., Levisetti, M., Pugh, W., Bonner-Weir, S., & Polonsky, K. S. (1998) · Diabetes · doi:10.2337/diabetes.47.3.358 · Cited by 551
Glucagon-like peptide-1 promotes islet cell growth and inhibits apoptosis in Zucker diabetic rats
Farilla, L., Hui, H., Bertolotto, C., Kang, E., Bulotta, A., Di Mario, U., & Perfetti, R. (2002) · Endocrinology · doi:10.1210/en.2002-220405 · Cited by 502
Self-citationPerfetti, R. (2000) · Endocrinology · doi:10.1210/en.141.12.4600 · Cited by 442
Self-citationDonath, M. Y., Gross, D. J., Cerasi, E., & Kaiser, N. (1999) · Diabetes · doi:10.2337/diabetes.48.4.738 · Cited by 405
Protection and Reversal of Excitotoxic Neuronal Damage by Glucagon-Like Peptide-1 and Exendin-4
Perry, T., Haughey, N. J., Mattson, M. P., Egan, J. M., & Greig, N. H. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.037481 · Cited by 380
Kassem, S. A., Ariel, I., Thornton, P. S., Scheimberg, I., & Glaser, B. (2000) · Diabetes · doi:10.2337/diabetes.49.8.1325 · Cited by 361
Yamaguchi, T., Pelling, J. C., Ramaswamy, N. T., Eppler, J. W., Wallace, D. P., Nagao, S., Rome, L. A., Sullivan, L. P., & Grantham, J. J. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00991.x · Cited by 355
Garcia-Ocaña, A., Takane, K. K., Syed, M. A., Philbrick, W. M., Vasavada, R. C., & Stewart, A. F. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.2.1226 · Cited by 247
Molecular steps of death receptor and mitochondrial pathways of apoptosis
Gupta, S. (2001) · Life Sciences · doi:10.1016/s0024-3205(01)01404-7 · Cited by 244
Frödin, M., Sekine, N., Roche, E., Filloux, C., Prentki, M., Wollheim, C. B., & Van Obberghen, E. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.14.7882 · Cited by 220
Montrose-Rafizadeh, C. (1999) · Endocrinology · doi:10.1210/en.140.3.1132 · Cited by 216
Structure—Function Analysis of Bcl-2 Family Proteins
Reed, J. C., Zha, H., Aime-Sempe, C., Takayama, S., & Wang, H.-G. (1996) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4899-0274-0_10 · Cited by 207
Bcl-2 and Bcl-2-Related Proteins in Apoptosis Regulation
Boise, L. H., Gottschalk, A. R., Quintáns, J., & Thompson, C. B. (1995) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-642-79437-7_8 · Cited by 206
Chen, R.-H., Su, Y.-H., Chuang, R. L., & Chang, T.-Y. (1998) · Oncogene · doi:10.1038/sj.onc.1202111 · Cited by 186
Boushey, R. P., Yusta, B., & Drucker, D. J. (2001) · PubMed · Cited by 150
Ehses, J. A., Pelech, S., Pederson, R. A., & McIntosh, C. H. S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205055200 · Cited by 135
Webster, C. R. L., & Anwer, S. M. (1998) · Hepatology · doi:10.1002/hep.510270519 · Cited by 118
Yusta, B., Boushey, R. P., & Drucker, D. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005510200 · Cited by 114
Drucker, D. J. (2001) · Current Pharmaceutical Design · doi:10.2174/1381612013397401 · Cited by 113
Counis, M. F., & Torriglia, A. (2000) · Biochemistry and Cell Biology · doi:10.1139/o00-051 · Cited by 108
Involvement of PARP and poly(ADP-ribosyl)ation in the early stages of apoptosis and DNA replication
Simbulan-Rosenthal, C. M., Rosenthal, D. S., Iyer, S., Boulares, H. A., & Smulson, M. E. (1999) · Springer eBooks · doi:10.1007/978-1-4419-8740-2_20 · Cited by 104
Hepatocyte growth factor protects cardiac myocytes against oxidative stress-induced apoptosis
Kitta, K., Day, R. M., Ikeda, T., & Suzuki, Y. (2001) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(01)00663-3 · Cited by 101
Myeloperoxidase Is Involved in H2O2-induced Apoptosis of HL-60 Human Leukemia Cells
Wagner, B. A., Buettner, G. R., Oberley, L. W., Darby, C. J., & Burns, C. P. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001434200 · Cited by 89
Involvement of PARP and poly(ADP-ribosyl)ation in the early stages of apoptosis and DNA replication
Simbulan-Rosenthal, C. M., Rosenthal, D. S., Iyer, S., Boulares, H. A., & Smulson, M. E. (1999) · Molecular and Cellular Biochemistry · doi:10.1023/a:1006988832729 · Cited by 82
Using -Cell Growth Factors to Enhance Human Pancreatic Islet Transplantation
García-Ocaña, A., Vasavada, R. C., Takane, K. K., Cebrián, A., López-Talavera, J. C., & Stewart, A. F. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.3.7315 · Cited by 78
Myklebust, J. H., Josefsen, D., Blomhoff, H. K., Levy, F. O., Naderi, S., Reed, J. C., & Smeland, E. B. (1999) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(199907)180:1<71::aid-jcp8>3.0.co;2-n · Cited by 75
HYDROGEN PEROXIDE INDUCES APOPTOSIS IN HUMAN HEPATOMA CELLS AND ALTERS CELL REDOX STATUS
Li, J., Huang, C., Zheng, R., Cui, K., & Li, J. (2000) · Cell Biology International · doi:10.1006/cbir.1999.0438 · Cited by 74
Matz, P. G., Copin, J., & Chan, P. H. (2000) · Stroke · doi:10.1161/01.str.31.10.2450 · Cited by 74
Augstein, P., Elefanty, A. G., Allison, J., & Harrison, L. C. (1998) · Diabetologia · doi:10.1007/s001250051080 · Cited by 71
Jiang, Y., Cypess, A. M., Muse, E. D., Wu, C.-R., Unson, C. G., Merrifield, R. B., & Sakmar, T. P. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.131200398 · Cited by 59
Zwain, I. H., Zwain, I. H., & Amato, P. (2001) · Endocrine Research · doi:10.1081/erc-100107184 · Cited by 56
Song, B. J., Soh, Y., Bae, M., Pie, J., Wan, J., & Jeong, K.-S. (2001) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(00)00247-7 · Cited by 54
Hydrogen peroxide, a messenger with too many roles?
Mittler, R., & Berkowitz, G. A. (2001) · Redox Report · doi:10.1179/135100001101536067 · Cited by 53
Sjöholm, Å. (1998) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400379 · Cited by 50
Apoptosis and disease progression in the spontaneously diabetic BB/S rat
Lally, F., Ratcliff, H., & Bone, A. J. (2001) · Diabetologia · doi:10.1007/s001250051621 · Cited by 35
Additive effect of Apo2L/TRAIL and Adeno-p53 in the induction of apoptosis in myeloma cell lines
Liu, Q., El‐Deiry, W. S., & Gazitt, Y. (2001) · Experimental Hematology · doi:10.1016/s0301-472x(01)00677-4 · Cited by 21
Ikeuchi, T., Shimoke, K., Kubo, T., Yamada, M., & Hatanaka, H. (1998) · PubMed · Cited by 20
Genetic and functional analysis of PARP, a DNA strand break-binding enzyme
Uchida, M., Hanai, S., Uematsu, N., Sawamoto, K., Okano, H., Miwa, M., & Uchida, K. (2001) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/s0027-5107(01)00110-5 · Cited by 18
Cited by
Drucker, D. J., & Nauck, M. A. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69705-5 · Cited by 3,896
Biology of Incretins: GLP-1 and GIP
Baggio, L. L., & Drucker, D. J. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.054 · Cited by 3,639
The biology of incretin hormones
Drucker, D. J. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.01.004 · Cited by 2,210
Buse, J. B., Rosenstock, J., Sesti, G., Schmidt, W. E., Montanya, E., Brett, J. H., Zychma, M., & Blonde, L. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60659-0 · Cited by 1,503
The role of incretins in glucose homeostasis and diabetes treatment
Kim, W., & Egan, J. M. (2008) · Pharmacological Reviews · doi:10.1124/pr.108.000604 · Cited by 824
Metadata
- Authors
- Hui, H., Nourparvar, A., Zhao, X., & Perfetti, R.
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2003-04-01
- Volume
- 144
- Issue
- 4
- Pages
- 1444-1455
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- OpenAlex
- W2026348270
- Cited by
- 307
- References
- 43
- FWCI
- 21.31
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.